Ikonisys S.A. (EPA:ALIKO)

Market Cap	21.32M
Revenue (ttm)	471.50K
Net Income (ttm)	-2.70M
Shares Out	14.02M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,734
Average Volume	891
Open	1.540
Previous Close	1.520
Day's Range	1.520 - 1.560
52-Week Range	1.280 - 1.710
Beta	0.72
RSI	38.56
Earnings Date	Jun 30, 2025

About Ikonisys

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFI...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 10
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIKO

Financial Performance

In 2023, Ikonisys's revenue was 448,557, a decrease of -27.28% compared to the previous year's 616,866. Losses were -2.27 million, -7.38% less than in 2022.